Literature DB >> 3872872

Comparative regional analysis of 2-fluorodeoxyglucose and methylglucose uptake in brain of four stroke patients. With special reference to the regional estimation of the lumped constant.

A Gjedde, K Wienhard, W D Heiss, G Kloster, N H Diemer, K Herholz, G Pawlik.   

Abstract

The glucose metabolic rate of the human brain can be measured with labeled deoxyglucose, using positron emission tomography, provided certain conditions are fulfilled. The original method assumed irreversible trapping of deoxyglucose metabolites in brain during the experimental period, and it further requires that a conversion factor between deoxyglucose and glucose, the "lumped constant," be known for the brain regions of interest. We examined the assumption of irreversible trapping of fluorodeoxyglucose metabolites in brain of four patients in 365 normal and 4 recently infarcted regions. The average net, steady-state rate of fluorodeoxyglucose (KD) accumulation in normal regions of the four patients was 0.025 ml g-1 min-1. We also examined the variability of the lumped constant. We first confirmed that methylglucose is not phosphorylated in the human brain. We then estimated the lumped constant from the regional distribution of labeled methylglucose in brain. The average (virtual) volume of distribution of labeled methylglucose in the normal regions was 0.46 ml g-1 and was the same in both gray and white matter structures. The average brain glucose content corresponding to this value was 1.3 mumol g-1, assuming a Michaelis constant (Kt) of 3.7 mM for glucose transport across the blood-brain barrier. The lumped constant varied insignificantly between 0.4 and 0.5 in most regions, with an overall average of 0.44. It did not vary significantly between the patients and was the same in gray and white matter structures, but was inversely related to the calculated metabolic rate. This observation indicates that metabolic rates calculated with a fixed lumped constant (e.g., 0.40) would be slightly underestimated at high metabolic rates and slightly overestimated at low metabolic rates. The average glucose metabolic rates of the 365 normal regions, in which gray matter regions prevailed by 20:1, was 32 mumol 100 g-1 min-1. The average glucose phosphorylation rate in white matter was 20 mumol 100 g-1 min-1 with a lumped constant of 0.45. In the recently infarcted areas, the lumped constants varied from 0.37 to 2.83, corresponding to glucose metabolic rates varying from 2 to 18 mumol 100 g-1 min-1. Two infarct types were identified. In one type, the phosphorylation-limited type, glucose content and the lumped constant were close to normal (1 mumol g-1 and 0.40, respectively). In the other, the transport/flow-limited type, the glucose content was low (0.2 mumol g-1), and the lumped constant in excess of unity. The evidence from the present study upholds the model of Sokoloff et al. in every detail.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3872872     DOI: 10.1038/jcbfm.1985.23

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  30 in total

Review 1.  Uses and limitations of positron emission tomography in clinical pharmacokinetics/dynamics (Part II).

Authors:  L L Ponto; J A Ponto
Journal:  Clin Pharmacokinet       Date:  1992-04       Impact factor: 6.447

2.  Diagnostic value of kinetic analysis using dynamic FDG PET in immunocompetent patients with primary CNS lymphoma.

Authors:  Yoshihiro Nishiyama; Yuka Yamamoto; Toshihide Monden; Yasuhiro Sasakawa; Nobuyuki Kawai; Katashi Satoh; Motoomi Ohkawa
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-07-29       Impact factor: 9.236

3.  Glucose metabolism in normal aging and Alzheimer's disease: Methodological and physiological considerations for PET studies.

Authors:  Lisa Mosconi
Journal:  Clin Transl Imaging       Date:  2013-08

4.  Longitudinal PET evaluation of cerebral glucose metabolism in rivastigmine treated patients with mild Alzheimer's disease.

Authors:  E Stefanova; A Wall; O Almkvist; A Nilsson; A Forsberg; B Långström; A Nordberg
Journal:  J Neural Transm (Vienna)       Date:  2005-07-29       Impact factor: 3.575

5.  PET imaging of ischemia-induced impairment of mitochondrial complex I function in monkey brain.

Authors:  Hideo Tsukada; Hiroyuki Ohba; Shingo Nishiyama; Masakatsu Kanazawa; Takeharu Kakiuchi; Norihiro Harada
Journal:  J Cereb Blood Flow Metab       Date:  2014-01-22       Impact factor: 6.200

6.  Non-stationary spatial filtering and accelerated curve fitting for parametric imaging with dynamic PET.

Authors:  K Herholz
Journal:  Eur J Nucl Med       Date:  1988

7.  Volume-normalized uptake rates with robust transportability from PET dual-time and Patlak analyses.

Authors:  Joseph A Thie
Journal:  Mol Imaging Biol       Date:  2009-12-01       Impact factor: 3.488

8.  Regional differences in local cerebral blood flow (LCBF) and glucose utilization (LCGU) in the basal ganglia after occlusion of the middle cerebral artery in rats.

Authors:  M Shibuya; N Arita; Y L Yamamoto
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

9.  Double-blind stereo-EEG and FDG PET study in severe partial epilepsies: are the electric and metabolic findings related?

Authors:  G Lucignani; L Tassi; F Fazio; L Galli; C Grana; A Del Sole; D Hoffman; S Francione; F Minicucci; P Kahane; C Messa; C Munari
Journal:  Eur J Nucl Med       Date:  1996-11

10.  Cerebral glucose metabolism in long-term survivors of childhood primary brain tumors treated with surgery and radiotherapy.

Authors:  Preben B Andersen; Katja Krabbe; Anne M Leffers; Marianne Schmiegelow; Søren Holm; Henning Laursen; Jørn R Müller; Olaf B Paulson
Journal:  J Neurooncol       Date:  2003-05       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.